Sensex, Nifty march higher on Covid-19 vaccine progress news; ONGC rises 6%

After touching a record intra-day high of 44,271.15, Sensex ended 194.90 points or 0.44 per cent higher at 44,077.15

BSE, markets
People walk past the Bombay Stock Exchange (BSE) building in Mumbai. Photo: Reuters
Press Trust of India
3 min read Last Updated : Nov 24 2020 | 1:23 AM IST
Equity benchmarks made a winning start to the week on Monday as positive results from another Covid-19 vaccine candidate bolstered investor confidence globally.

After touching a record intra-day high of 44,271.15, Sensex ended 194.90 points or 0.44 per cent higher at 44,077.15. Similarly, the broader Nifty rose 67.40 points or 0.52 per cent to close at 12,926.45.

ONGC was the top performer on the Sensex chart, surging 6.84 per cent, followed by IndusInd Bank, Infosys, Tech Mahindra, Bajaj Finserv, Reliance Industries, HCL, and TCS.

Index heavyweight Reliance Industries climbed 2.72 per cent, acco­u­nting for most of the Sensex’s gains.

On the other hand, the Nifty Financial Services index was down 1.07 per cent, but its constituents saw a good bit of action. Among gainers, Bajaj Holdings was up 7.8 per cent, while Shriram Transport, Chola Investment, M&M Finance and Bajaj Finserv were among top gainers—up 1.8 – 4.2 per cent. The losers were HDFC (down 3.5 per cent), followed by ICICI Bank, Axis Bank, SBI Life and SBI, which were down 1.7 – 2.5 per cent.

HDFC, ICICI Bank, Axis Bank, SBI, and M&M were among the main laggards, slumping up to 3.55 per cent.

Global equities were on the upswing after Oxford University and AstraZeneca announced that their Covid-19 vaccine candidate was found to be around 90 per cent effective in preventing the disease.

This is the third major vaccine trial to have reported encouraging results, after Moderna and Pfizer came out with positive Phase 3 data.

"While global cues remained favourable, a sharp rebound in IT, pharma, metals and Reliance Industries led domestic equities to register further gains. However, profit booking was witnessed in select heavyweight financials after recommendation of IWG (Internal Working Group) of RBI did not favour them much, which led financials to end in red today.

"Additionally, as expected strong buying in mid-cap and small-cap stocks remained visible in the backdrop of improving earnings outlook scenario. Nifty is poised to cross psychological 13,000 mark shortly. We believe improved prospects of strong corporate earnings should continue to attract foreign participation in Indian equities, which bodes well for markets," said Binod Modi, Head- Strategy at Reliance Securities.

BSE IT, oil and gas, energy, teck, healthcare, utilities and power indices rallied as much as 2.89 per cent, while telecom, bankex, finance and consumer durables closed lower.

Broader BSE midcap and smallcap indices jumped up to 1.37 per cent.

Elsewhere in Asia, bourses in Shanghai, Hong Kong and Seoul ended with significant gains.

Stock exchanges in Europe were also trading on a positive note.

Meanwhile, Brent crude futures, the global oil benchmark, rose 1.64 per cent to USD 45.81 per barrel.

The rupee appreciated by 5 paise to settle at 74.11 against the US dollar.

Foreign institutional investors remained net buyers in the capital market as they purchased shares worth Rs 3,860.78 crore on Friday, according to provisional exchange data.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusMarkets Sensex NiftyCoronavirus VaccineAstraZeneca

Next Story